Advancing PHBV Biomedical Potential with the Incorporation of Bacterial Biopigment Prodigiosin
Аутори
Ponjavić, MarijanaMalagurski, Ivana
Lazić, Jelena
Jeremić, Sanja
Pavlović, Vladimir B.
Prlainović, Nevena
Maksimović, Vesna
Ćosović, Vladan
Atanase, Leonard Ionut
Freitas, Filomena
Matos, Mariana
Nikodinović-Runić, Jasmina
Чланак у часопису (Објављена верзија)
Метаподаци
Приказ свих података о документуАпстракт
The quest for sustainable biomaterials with excellent biocompatibility and tailorableproperties has put polyhydroxyalkanoates (PHAs) into the research spotlight. However, high productioncosts and the lack of bioactivity limit their market penetration. To address this, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) was combined with a bacterial pigment with stronganticancer activity, prodigiosin (PG), to obtain functionally enhanced PHBV-based biomaterials. Thesamples were produced in the form of films 115.6–118.8 m in thickness using the solvent castingmethod. The effects of PG incorporation on the physical properties (morphology, biopolymer crystallinityand thermal stability) and functionality of the obtained biomaterials were investigated. PGhas acted as a nucleating agent, in turn affecting the degree of crystallinity, thermal stability andmorphology of the films. All samples with PG had a more organized internal structure and highermelting and degradation temperatures. The ca...lculated degree of crystallinity of the PHBV copolymerwas 53%, while the PG1, PG3 and PG3 films had values of 64.0%, 63.9% and 69.2%, respectively.Cytotoxicity studies have shown the excellent anticancer activity of films against HCT116 (coloncancer) cells, thus advancing PHBV biomedical application potential.
Кључне речи:
prodigiosin / polyhydroxyalkanoate / PHBV / anticancer activity / film / drug delivery / biopolymer crystallinity / biocompatibilityИзвор:
International Journal of Molecular Sciences, 2023, 24, 3, 1906-Финансирање / пројекти:
- Министарство науке, технолошког развоја и иновација Републике Србије, институционално финансирање - 200042 (Универзитет у Београду, Институт за молекуларну генетику и генетичко инжењерство) (RS-MESTD-inst-2020-200042)
- BioECOLogics - Value-added biologics through eco-sustainable routes (RS-ScienceFundRS-Ideje-7730810)
- Associate Laboratory Institute for Health and Bioeconomy—i4HB [project LA/P/0140/202019]
- FCT—Fundação para a Ciência e a Tecnologia and Research Unit on Applied Molecular Biosciences - UCIBIO - [UIDP/04378/2020 and UIDB/04378/2020]
Институција/група
VinčaTY - JOUR AU - Ponjavić, Marijana AU - Malagurski, Ivana AU - Lazić, Jelena AU - Jeremić, Sanja AU - Pavlović, Vladimir B. AU - Prlainović, Nevena AU - Maksimović, Vesna AU - Ćosović, Vladan AU - Atanase, Leonard Ionut AU - Freitas, Filomena AU - Matos, Mariana AU - Nikodinović-Runić, Jasmina PY - 2023 UR - https://vinar.vin.bg.ac.rs/handle/123456789/10660 AB - The quest for sustainable biomaterials with excellent biocompatibility and tailorableproperties has put polyhydroxyalkanoates (PHAs) into the research spotlight. However, high productioncosts and the lack of bioactivity limit their market penetration. To address this, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) was combined with a bacterial pigment with stronganticancer activity, prodigiosin (PG), to obtain functionally enhanced PHBV-based biomaterials. Thesamples were produced in the form of films 115.6–118.8 m in thickness using the solvent castingmethod. The effects of PG incorporation on the physical properties (morphology, biopolymer crystallinityand thermal stability) and functionality of the obtained biomaterials were investigated. PGhas acted as a nucleating agent, in turn affecting the degree of crystallinity, thermal stability andmorphology of the films. All samples with PG had a more organized internal structure and highermelting and degradation temperatures. The calculated degree of crystallinity of the PHBV copolymerwas 53%, while the PG1, PG3 and PG3 films had values of 64.0%, 63.9% and 69.2%, respectively.Cytotoxicity studies have shown the excellent anticancer activity of films against HCT116 (coloncancer) cells, thus advancing PHBV biomedical application potential. T2 - International Journal of Molecular Sciences T1 - Advancing PHBV Biomedical Potential with the Incorporation of Bacterial Biopigment Prodigiosin VL - 24 IS - 3 SP - 1906 DO - 10.3390/ijms24031906 ER -
@article{ author = "Ponjavić, Marijana and Malagurski, Ivana and Lazić, Jelena and Jeremić, Sanja and Pavlović, Vladimir B. and Prlainović, Nevena and Maksimović, Vesna and Ćosović, Vladan and Atanase, Leonard Ionut and Freitas, Filomena and Matos, Mariana and Nikodinović-Runić, Jasmina", year = "2023", abstract = "The quest for sustainable biomaterials with excellent biocompatibility and tailorableproperties has put polyhydroxyalkanoates (PHAs) into the research spotlight. However, high productioncosts and the lack of bioactivity limit their market penetration. To address this, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) was combined with a bacterial pigment with stronganticancer activity, prodigiosin (PG), to obtain functionally enhanced PHBV-based biomaterials. Thesamples were produced in the form of films 115.6–118.8 m in thickness using the solvent castingmethod. The effects of PG incorporation on the physical properties (morphology, biopolymer crystallinityand thermal stability) and functionality of the obtained biomaterials were investigated. PGhas acted as a nucleating agent, in turn affecting the degree of crystallinity, thermal stability andmorphology of the films. All samples with PG had a more organized internal structure and highermelting and degradation temperatures. The calculated degree of crystallinity of the PHBV copolymerwas 53%, while the PG1, PG3 and PG3 films had values of 64.0%, 63.9% and 69.2%, respectively.Cytotoxicity studies have shown the excellent anticancer activity of films against HCT116 (coloncancer) cells, thus advancing PHBV biomedical application potential.", journal = "International Journal of Molecular Sciences", title = "Advancing PHBV Biomedical Potential with the Incorporation of Bacterial Biopigment Prodigiosin", volume = "24", number = "3", pages = "1906", doi = "10.3390/ijms24031906" }
Ponjavić, M., Malagurski, I., Lazić, J., Jeremić, S., Pavlović, V. B., Prlainović, N., Maksimović, V., Ćosović, V., Atanase, L. I., Freitas, F., Matos, M.,& Nikodinović-Runić, J.. (2023). Advancing PHBV Biomedical Potential with the Incorporation of Bacterial Biopigment Prodigiosin. in International Journal of Molecular Sciences, 24(3), 1906. https://doi.org/10.3390/ijms24031906
Ponjavić M, Malagurski I, Lazić J, Jeremić S, Pavlović VB, Prlainović N, Maksimović V, Ćosović V, Atanase LI, Freitas F, Matos M, Nikodinović-Runić J. Advancing PHBV Biomedical Potential with the Incorporation of Bacterial Biopigment Prodigiosin. in International Journal of Molecular Sciences. 2023;24(3):1906. doi:10.3390/ijms24031906 .
Ponjavić, Marijana, Malagurski, Ivana, Lazić, Jelena, Jeremić, Sanja, Pavlović, Vladimir B., Prlainović, Nevena, Maksimović, Vesna, Ćosović, Vladan, Atanase, Leonard Ionut, Freitas, Filomena, Matos, Mariana, Nikodinović-Runić, Jasmina, "Advancing PHBV Biomedical Potential with the Incorporation of Bacterial Biopigment Prodigiosin" in International Journal of Molecular Sciences, 24, no. 3 (2023):1906, https://doi.org/10.3390/ijms24031906 . .